Clinical, Biological, Immunological and Therapeutic Profile of Patients Co-Infected with HIV-HBV and/or HCV in Kinshasa, in the Democratic Republic of the Congo: Multicenter Cross-Sectional Study
- 1 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 2 Departement of Family Medicine and Primary Health Care, Protestant University in Congo, Kinshasa, Democratic Republic of the Congo
- 3 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 4 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 5 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 6 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 7 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 8 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 9 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 10 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 11 Garstroenterology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 12 Department of Nephrology, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 13 Department of Clinical Biology, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 14 Department of Infectious Diseases, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 15 Department of Cardiology, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
- 16 Unit of Gastroenterology, Clinic Marie Yvette, Kinshasa, Democratic Republic of the Congo
Abstract
Background and Objective: HIV infection is often associated with HBV and HCV infection, together leading to high morbidity and mortality in developing countries. The objective of this study is to describe the clinical, biological, immunological and therapeutic profile of patients co-infected with HIV-HBV and/or HCV. Methods: A cross-sectional and descriptive study including 180 people living with HIV (PLWHIV) in the city of Kinshasa province was conducted. Socio - demographic, clinical, biological and serological characteristics were analyzed. Results: The frequency of HIV-HBV/HCV co-infection was 23.9%. The distribution of age and sex of patients did not differ significantly according to co-infection status. The notion of pedicure and manicure was significantly more observed in patients free from viral hepatitis (51.1% versus 32.6%, p = 0.034). The median duration of knowledge of the HIV status which was longer in the co-infected (4 years versus 2 years, p = 0.022). A lower median level of GPT was observed in co-infected compared to other patients (14 IU/L vers us 20 IU/L, p = 0.041). Serum albumin (3.1 g/L versus 3.3 g/L, p = 0.034) and prothrombin (58.3% versus 65.6%, p = 0.045) were lower in HIV co-infected-VHB and/or VHC. The median INR was higher in co-infected than in other patients (1.6 versus 1.4; p = 0.009). Patients without therapy Antiretroviral (TARV) medication were more numerous in co-infected (20.9% versus 8.0%, p = 0.025). Conclusions: The profile of PLWHIV was dominat ed by the presence of pedicures and manicures with high transaminases and without anti-viral treatment.
- Ferri, C., Sebastiani, M., Giuggioli, D., Colaci, M., Fallahi, P., Piluso, A., et al. (2015) Hepatitis C Virus Syndrome: A Constellation of Organ- and Non-Organ Specific Autoimmune Disorders, B-Cell Non-Hodgkin’s Lymphoma, and Cancer. World Journal of Hepatology, 7, 327-343. https://doi.org/10.4254/wjh.v7.i3.327
- Seaberg, E.C., Witt, M.D., Jacobson, L.P., Detels, R., Rinaldo, C.R., Margolick, J.B., et al. (2015) Spontaneous Clearance of the Hepatitis C Virus among Men Who Have Sex with Men. Clinical Infectious Diseases, 61, 1381-1388.
- Piroth, L., Larsen, C., Binquet, C., Alric, L., Auperin, I., Chaix, M.L., et al. (2010) Treatment of Acute Hepatitis C in Human Immunodeficiency Virus-Infected Patients: The HEPAIG Study. Hepatology, 52, 1915-1921. https://doi.org/10.1002/hep.23959
- Thomson, E.C., Fleming, V.M., Main, J., Klenerman, P., Weber, J., Eliahoo, J., et al. (2011) Predicting Spontaneous Clearance of Acute Hepatitis C Virus in a Large Cohort of HIV-1-Infected Men. Gut, 60, 837-845. https://doi.org/10.1136/gut.2010.217166
- Ingiliz, P., Steininger, K., Schuetze, M., Dupke, S., Carganico, A., Krznaric, I., et al. (2014) Acute Hepatitis C Virus (HCV) Infection in the Setting of HIV Coinfection: A Single-Centre 10-Year Follow-Up. Journal of the International AIDS Society, 17, Article ID: 19638. https://doi.org/10.7448/IAS.17.4.19638
- Ward, C. and Lee, V. (2014) Experience of Acute Hepatitis C and HIV Co-Infection in an Inner City Clinic in the UK. Journal of the International AIDS Society, 17, Article ID: 19639. https://doi.org/10.7448/IAS.17.4.19639
- Hullegie, S.J., Van Den Berk, G.E., Leyten, E.M., Arends, J.E., Lauw, F.N., Van Der Meer, J.T., et al. (2016) Acute Hepatitis C in the Netherlands: Characteristics of the Epidemic in 2014. Clinical Microbiology and Infection, 22, 209.E1-209.E3. https://doi.org/10.1016/j.cmi.2015.10.012
- Wandeler, G., Schlauri, M., Jaquier, M.E., Rohrbach, J., Metzner, K.J., Fehr, J., et al. (2015) Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes between 1991 and 2013. Open Forum Infect Dis, 2, ofv026. https://doi.org/10.1093/ofid/ofv026
- Larrubia, J.R., Moreno-Cubero, E., Lokhande, M.U., Garcia-Garzon, S., Lazaro, A., Miquel, J., et al. (2014) Adaptive Immune Response During Hepatitis C Virus Infection. World Journal of Gastroenterology, 20, 3418-3430. https://doi.org/10.3748/wjg.v20.i13.3418
- Gonzalez, V.D., Falconer, K., Blom, K.G., Reichard, O., Morn, B., Laursen, A.L., et al. (2009) High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment. Journal of Virology, 83, 11407-11411. https://doi.org/10.1128/JVI.01211-09